Last checked at 14 Oct 2016 07:00
14 October 2016
Revolymer plc
("Revolymer" or "the Company")
Director's Dealings
Â
Revolymer (AIM: REVO) has been notified that on 13 October 2016 there were purchases by certain Non-Executive Directors of the Company of 1p nominal value ordinary shares in the Company ("Ordinary Shares"), as detailed in the following table. This table also details the resultant holdings of these individuals immediately following the purchases.
Â
Director | Ordinary Shares Purchased on 13 October 2016 | Purchase Price per Ordinary Share | Resultant interest in the Company (Ordinary Shares) | Resultant interest in the Company (% of Issued Share Capital) |
Bryan Dobson | 14,500 | 34 pence | 83,500 | 0.11 |
John Keenan | 150,000 | 34 pence | 931,750 | 1.18 |
Michael Townend | 29,000 | 34 pence | 64,940 | 0.08 |
Total | 193,500 | 34 pence | 1,080,190 | 1.37 |
Â
Â
Ends
Â
For further information please contact:
Â
Revolymer plc | +44 (0) 1244 283 500 |
Kevin Matthews Rob Cridland  | |
Panmure Gordon (UK) Limited | +44 (0) 20 7886 2500 |
Adam James / Fabien Holler (Corporate Finance) Charles Leigh-Pemberton (Corporate Broking) |
Â
About Revolymer
Revolymer is an AIM quoted company (registered number 08024489) whose vision is to be a specialty chemicals business focused on controlled release, responsive systems and delivery systems based on its expertise in the design and synthesis of polymers that improve the functional performance of its customers' products, thereby generating high margin business.
www.revolymer.com